David Harrison FRSC

Vp, Medicinal Chemistry at NodThera

David Harrison FRSC is a VP of Medicinal Chemistry at NodThera, a clinical-stage biotech company focused on developing small molecule NLRP3 inflammasome modulators for various disorders. Prior to this, David worked at Takeda for 8 years, initially as a Medicinal Chemist and later as a Senior Director and Director in the same field. David also has experience as a Medicinal Chemist at GSK, where David researched Hepatitis C virus inhibitors and holds patents in this area. David's career in medicinal chemistry began as an Industrial Placement Student at Novartis, where David contributed to a project that reached Phase III for severe asthma. David holds a degree in Chemistry from the University of Southampton, graduating in 2004.

Links

Previous companies

Novartis logo

Org chart